Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/316853
Vitamins and Dietary Supplements in Brazil
Description:
Results from research conducted by IBGE (Brazilian Institute of Geography and Statistics) show that the Brazilian diet, whilst rich in rice and beans, which contain good nutritional value, is also rich in calories and poor in nutrients. Brazilians’ consumption of fruit and vegetables is below recommended levels, whilst consumption of sugar-added beverages such as juice and soft drinks is above what is recommended in order to maintain a healthy diet.
The Vitamins and Dietary Supplements in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Dietary Supplements, Paediatric Vitamins and Dietary Supplements, Tonics and Bottled Nutritive Drinks, Vitamins.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Vitamins and Dietary Supplements market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
The Vitamins and Dietary Supplements in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Dietary Supplements, Paediatric Vitamins and Dietary Supplements, Tonics and Bottled Nutritive Drinks, Vitamins.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Vitamins and Dietary Supplements market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Contents:
VITAMINS AND DIETARY SUPPLEMENTS IN BRAZIL
Euromonitor International
May 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Vitamins
Dietary Supplements
Switches
Competitive Landscape
Prospects
Category Data
Summary 1 Dietary Supplements: Brand Ranking by Positioning 2011
Table 1 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
Table 2 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
Table 3 Dietary Supplements by Positioning 2006-2011
Table 4 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
Table 5 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
Table 6 Vitamins Brand Shares by Value 2008-2011
Table 7 Dietary Supplements Brand Shares by Value 2008-2011
Table 8 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
Table 9 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
Aché Laboratórios Farmacêuticos SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 2 Aché Laboratórios Farmacêuticos SA: Key Facts
Summary 3 Aché Laboratórios Farmacêuticos SA: Operational Indicators
Company Background
Production
Summary 4 Aché Laboratórios Farmacêuticos SA: Production Statistics 2011
Competitive Positioning
Summary 5 Aché Laboratórios Farmacêuticos SA: Competitive Position 2011
Bayer (brasil) SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 6 Bayer (Brasil) SA: Key Facts
Summary 7 Bayer (Brasil) SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Bayer (Brasil) SA: Competitive Position 2011
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 9 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Company Background
Production
Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2011
Competitive Positioning
Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2011
Ems SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 12 EMS SA: Key Facts
Summary 13 EMS SA: Operational Indicators
Company Background
Production
Summary 14 EMS SA: Production Statistics 2011
Competitive Positioning
Summary 15 EMS SA: Competitive Position 2011
Hypermarcas SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 16 Hypermarcas SA: Key Facts
Summary 17 Hypermarcas SA: Operational Indicators
Company Background
Production
Summary 18 Hypermarcas SA: Production Statistics 2011
Competitive Positioning
Summary 19 Hypermarcas SA: Competitive Position 2011
Sanofi-aventis Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 20 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Summary 21 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
Company Background
Production
Summary 22 Sanofi-Aventis Farmacêutica Ltda: Production Statistics 2011
Competitive Positioning
Summary 23 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2011
Executive Summary
Consumer Health Continues To Show Double-digit Growth
Back To Basics: Non-prescription Drugs Are Expected To Return To OTC Status
Acquisitions Are Expected To Continue As Market Growth Attracts Investors
Mergers and Acquisitions in Parapharmacies/drugstores
A Domestic Pharmaceutical Company Is Created To Produce Biotechnological Drugs
Key Trends and Developments
Anvisa Is Expected To Change the Rules for Sales of Non-prescription Drugs
Vitamins and Dietary Supplements Suffers From Deficient Regulation
Price Control Tools Keep Adjustments Below Inflation, But Are Not Sufficient
Market Growth Drives Company Activity
Domestic Companies Join Forces To Produce Biotechnological Remedies
Market Indicators
Table 10 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 11 Life Expectancy at Birth 2006-2011
Market Data
Table 12 Sales of Consumer Health by Category: Value 2006-2011
Table 13 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 14 Consumer Health Company Shares 2007-2011
Table 15 Consumer Health Brand Shares 2008-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
De-reimbursement
Generics
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 24 Research Sources
Euromonitor International
May 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Vitamins
Dietary Supplements
Switches
Competitive Landscape
Prospects
Category Data
Summary 1 Dietary Supplements: Brand Ranking by Positioning 2011
Table 1 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
Table 2 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
Table 3 Dietary Supplements by Positioning 2006-2011
Table 4 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
Table 5 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
Table 6 Vitamins Brand Shares by Value 2008-2011
Table 7 Dietary Supplements Brand Shares by Value 2008-2011
Table 8 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
Table 9 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
Aché Laboratórios Farmacêuticos SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 2 Aché Laboratórios Farmacêuticos SA: Key Facts
Summary 3 Aché Laboratórios Farmacêuticos SA: Operational Indicators
Company Background
Production
Summary 4 Aché Laboratórios Farmacêuticos SA: Production Statistics 2011
Competitive Positioning
Summary 5 Aché Laboratórios Farmacêuticos SA: Competitive Position 2011
Bayer (brasil) SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 6 Bayer (Brasil) SA: Key Facts
Summary 7 Bayer (Brasil) SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Bayer (Brasil) SA: Competitive Position 2011
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 9 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Company Background
Production
Summary 10 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Production Statistics 2011
Competitive Positioning
Summary 11 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2011
Ems SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 12 EMS SA: Key Facts
Summary 13 EMS SA: Operational Indicators
Company Background
Production
Summary 14 EMS SA: Production Statistics 2011
Competitive Positioning
Summary 15 EMS SA: Competitive Position 2011
Hypermarcas SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 16 Hypermarcas SA: Key Facts
Summary 17 Hypermarcas SA: Operational Indicators
Company Background
Production
Summary 18 Hypermarcas SA: Production Statistics 2011
Competitive Positioning
Summary 19 Hypermarcas SA: Competitive Position 2011
Sanofi-aventis Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 20 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Summary 21 Sanofi-Aventis Farmacêutica Ltda: Operational Indicators
Company Background
Production
Summary 22 Sanofi-Aventis Farmacêutica Ltda: Production Statistics 2011
Competitive Positioning
Summary 23 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2011
Executive Summary
Consumer Health Continues To Show Double-digit Growth
Back To Basics: Non-prescription Drugs Are Expected To Return To OTC Status
Acquisitions Are Expected To Continue As Market Growth Attracts Investors
Mergers and Acquisitions in Parapharmacies/drugstores
A Domestic Pharmaceutical Company Is Created To Produce Biotechnological Drugs
Key Trends and Developments
Anvisa Is Expected To Change the Rules for Sales of Non-prescription Drugs
Vitamins and Dietary Supplements Suffers From Deficient Regulation
Price Control Tools Keep Adjustments Below Inflation, But Are Not Sufficient
Market Growth Drives Company Activity
Domestic Companies Join Forces To Produce Biotechnological Remedies
Market Indicators
Table 10 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 11 Life Expectancy at Birth 2006-2011
Market Data
Table 12 Sales of Consumer Health by Category: Value 2006-2011
Table 13 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 14 Consumer Health Company Shares 2007-2011
Table 15 Consumer Health Brand Shares 2008-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
De-reimbursement
Generics
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 24 Research Sources
Contents:
Demographic and cultural factors expected to drive sales of the OTC healthcare industry
Brazil's ageing population will boost sales of OTC healthcare over the forecast period and beyond, as it is likely
to need further medical assistance and have higher expenditure on healthcare products. Self-medication is
another aspect that is likely to boost sales of OTC healthcare products, especially among consumers who don't
want to spend time visiting a doctor and take time off work. This sort of behaviour is particularly characteristic
of less affluent consumers, as the public health system is very inefficient in Brazil.
Healthy sales in 2005
In 2005, sales of OTC healthcare increased by 9% in current value terms over 2004. The positive sales
performance is mostly attributed to price adjustments, rather than volume growth, as there was no improvement
in the population's purchasing power, which plays an important role in pushing drugs sales up. A larger number
of consumers were also in debt.
Brazil's ageing population will boost sales of OTC healthcare over the forecast period and beyond, as it is likely
to need further medical assistance and have higher expenditure on healthcare products. Self-medication is
another aspect that is likely to boost sales of OTC healthcare products, especially among consumers who don't
want to spend time visiting a doctor and take time off work. This sort of behaviour is particularly characteristic
of less affluent consumers, as the public health system is very inefficient in Brazil.
Healthy sales in 2005
In 2005, sales of OTC healthcare increased by 9% in current value terms over 2004. The positive sales
performance is mostly attributed to price adjustments, rather than volume growth, as there was no improvement
in the population's purchasing power, which plays an important role in pushing drugs sales up. A larger number
of consumers were also in debt.
Companies Mentioned
Aventis Pharma Ltda
DM Indústria Farmacêutica Ltda
Bayer SA
Cadbury Adams Indústria e Comércio de ProdutosAlimentícios Ltda
Boehringer Ingelheim do Brasil Química eFarmacêutica Ltda
Altana Pharma Ltda
Bristol-Myers Squibb Brasil SA
Janssen-Cilag Farmaceutica Ltda
Laboratórios Wyeth Whitehall Ltda
Achê Laboratórios Farmacêuticos SA
Procter & Gamble do Brasil SA
GlaxoSmithKline Brasil ltda
Laboratório Canonne Ltda
Schering-Plough Farmacêutica SA
Sanofi-Synthélabo Ltda
Johnson & Johnson Indústria e Comércio Ltda
Laboratório Stiefel Ltda
Pfizer Ltda,
Laboratório Riclan SA
Merck SA Indústrias Químicas
Novartis Biociências SA
Indústria de Produtos Alimentícios Cory Ltda
Farmasa Laboratório
Americano de Farmacoterapia SA
Galderma Brasil Ltda
EMS Indústria Farmacêutica Ltda
Herbalife International Do Brasil Ltda
Marjan Indústria e Comércio Ltda
Nature's Sunshine
Produtos Naturais Ltda
Barrenne Indústria Farmacêutica Ltda
União Química
Farmacêutica Nacional SA
Warner-Lambert
Indústria e Comércio Ltda
SmithKline Beecham
Brasil Ltda
Knoll Produtos Químicos
e Farmacêuticos Ltda
DM Indústria Farmacêutica Ltda
Bayer SA
Cadbury Adams Indústria e Comércio de ProdutosAlimentícios Ltda
Boehringer Ingelheim do Brasil Química eFarmacêutica Ltda
Altana Pharma Ltda
Bristol-Myers Squibb Brasil SA
Janssen-Cilag Farmaceutica Ltda
Laboratórios Wyeth Whitehall Ltda
Achê Laboratórios Farmacêuticos SA
Procter & Gamble do Brasil SA
GlaxoSmithKline Brasil ltda
Laboratório Canonne Ltda
Schering-Plough Farmacêutica SA
Sanofi-Synthélabo Ltda
Johnson & Johnson Indústria e Comércio Ltda
Laboratório Stiefel Ltda
Pfizer Ltda,
Laboratório Riclan SA
Merck SA Indústrias Químicas
Novartis Biociências SA
Indústria de Produtos Alimentícios Cory Ltda
Farmasa Laboratório
Americano de Farmacoterapia SA
Galderma Brasil Ltda
EMS Indústria Farmacêutica Ltda
Herbalife International Do Brasil Ltda
Marjan Indústria e Comércio Ltda
Nature's Sunshine
Produtos Naturais Ltda
Barrenne Indústria Farmacêutica Ltda
União Química
Farmacêutica Nacional SA
Warner-Lambert
Indústria e Comércio Ltda
SmithKline Beecham
Brasil Ltda
Knoll Produtos Químicos
e Farmacêuticos Ltda
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1582661
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Thursday, May 23, 2013
4:06:41 PM
4:06:41 PM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
Vitamins and Dietary Supplements in Brazil
Web Address
http://www.researchandmarkets.com/reports/316853
Office Code
OC8DIQSOMPSUVX
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price | Electronic (PDF) - Single User |
|
EURO€ 692.00 |
|---|---|---|
| Electronic (PDF) - Site License |
|
EURO€ 1,384.00 |
| Electronic (PDF) - Enterprisewide |
|
EURO€ 2,075.00 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Thursday, May 23, 2013
4:06:41 PM
4:06:41 PM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp